MicroPhage (Longmont, CO) early-stage developer of bacteriophage-based bacterial identification and antibiotic susceptibility and resistance testing, closed $11M Series A financing.
Participants include ?
GangaGen (Palo Alto, CA) developer of bacteriophage-based products to treat bacterial infections, closed a $5.4M Series E financing. Participants include ATEL Ventures, Otsuka Pharmaceutical Co. and ICF Ltd..